Phase 1 Study of TG-1701, a Selective Irreversible Inhibitor of Bruton's Tyrosine Kinase (BTK), in Patients with Relapsed/Refractory B-Cell Malignancies

Chan Y Cheah, Nicholas Wickham, Costas K Yannakou, Katharine L Lewis, Chi-Hung Hui, Pek Sang Tang, Tejasvi Turpuseema, Hari P Miskin, Jian-Ping Tang, Emmanuel Normant, Alejandro D Ricart, Constantine S Tam